ISSN (On-line) 1678-2925
Home
About
Brief History
Open Science Compliance
Publication Ethics
Focus and Scope
Digital Preservation
Editorial Policy
Ethics Committee
Copyright License
Issues
Current Issue
Previous
Supplements
Ahead of print
COMMENTED PAPERS - EDITORS CHOICE
Advanced Search
Editorial Board
Submission
Instructions to Authors
Submission of articles
Required Documents
Editorial Responsibilities
Charges Fees
Conflict of interest
Media
Videos
Podcasts
Contact
Home
Past Issues
Summary Vol.81 Issue
1 / 2018
Article
Article
Send this article by email
Artigo Original
Qual a dose de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva: menor ou maior dose?
Submission is temporarily unavailable. reCAPTCHA validation has not been configured yet.
Recipient e-mail
Separate email by comma. E.g. (
[email protected]
,
[email protected]
)
Name
E-mail
Message
Read in Portuguese
XML
Print
PDF English
Share
▼
Send this article by email
Submit a comment
Mendeley
SciELO
Pocket
Share on Facebook
Share on Twitter
Share on Linkedin
Share on WhatsApp
How to cite this article:
Dikci S, Ceylan OM, Demirel S, Yılmaz T. Qual a dose de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva: menor ou maior dose?. Arq. Bras. Oftalmol. 2018;81(1):12-7. 10.5935/0004-2749.20180005
Export citation
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
